Mandy H. Kim focuses her practice on intellectual property litigation. Mandy has significant experience managing complex litigations across a wide range of technologies, including in the life sciences, biotechnology, medical devices, computer hardware and software, and consumer electronics industries. Mandy routinely handles motion practice, fact and expert discovery matters, and has litigated a number of cases from pleadings through trial and/or settlement. She has represented clients in federal and state courts, and before the International Trade Commission.
While in law school, Mandy earned specialized certificates from the Palmer Center for Entrepreneurship and the Law and Straus Institute for Dispute Resolution and received several awards. She also was managing editor of the Journal of Business Entrepreneurship and the Law and served as a law clerk in the Office of the City Attorney (Los Angeles), Intellectual Property Unit, General Counsel Division.
Prior to law school, Mandy was a research associate. She has also authored a number of publications, and worked as a technology transfer specialist in the Office of Intellectual Property, UCLA. Mandy earned her bachelor’s and master’s degrees in microbiology, immunology and molecular genetics.
Counsel for Amgen Inc. in a patent infringement case involving novel antibody therapeutics for the treatment of high cholesterol, Amgen Inc. v. Sanofi et al., Case No. 14-1317-SLR (achieving a full victory after a one week jury trial)
Counsel for Ambry Genetics in a patent infringement case involving patents claiming human DNA sequences, In Re BRCA1- and BRCA2-Based Hereditary Cancer Test Patent Litigation, Case No. 2:14-MD-2510-RJS (reached favorable settlement with plaintiffs following a favorable Federal Circuit decision that disposed of a number of claims at issue)
Counsel for Panasonic in several matters before the International Trade Commission, In the Matter of Certain Digital Media Devices, Including Televisions, Blu-Ray Disc Players, Home Theater Systems, Tablets and Mobile Phones, Components Thereof and Associated Software, Inv. No. 337-TA-882 (resulted in an initial determination of no infringement, invalidity and no domestic industry) and In the Matter of Certain Optical Disc Drives, Components Thereof, and Products Containing the Same, Inv. No. 337-TA-897 (settled favorably on the eve of trial)
Counsel for HTC in a patent infringement action before the International Trade Commission, In re Certain Electronic Devices, Including Mobile Phones and Tablet Computers and Components Thereof, Inv. No. 337-TA-847, alleging 23 smartphones and tablet products infringed nine patents (the matter was tried before ALJ and ultimately led to a global settlement of all claims)
Counsel for Tolmar in a patent infringement action involving patents relating to treatment of psoriasis, LEO Pharma, A/S v. Tolmar, Inc., US District Court for the District of Delaware, 10-269-SLR (achieving a favorable settlement after a bench trial)
Counsel for Sandoz, Inc., in several matters relating to patent litigations brought under the Hatch-Waxman Act, Cephalon, Inc. and Cima Labs, Inc. v. Sandoz, Inc., US District Court for the District of Delaware, 10-330-SLR (settled favorably on the eve of trial) and Warner Chilcott Company, LLC, et al. v. Sandoz, Inc., US District Court for the District of New Jersey, 2:10-cv-0511-WJM-MF (settled favorably on the eve of trial)
Super Lawyers 2014 to 2019, Southern California Rising Stars
American Jurisprudence Award for Intellectual Property Survey, and for Selected Issues in Dispute Resolution—Intellectual Property
Witkin Award for Selected Issues in Dispute Resolution—Intellectual Property
Orange County Coalition for Diversity in the Law, Treasurer
Public Law Center, PLC Advocate
Pepperdine University School of Law, JD, cum laude, 2009
University of California – Los Angeles, MS, Microbiology, Immunology and Molecular Genetics, 2005
University of California – Los Angeles, BS, Microbiology, Immunology and Molecular Genetics, 2002
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.